Scheduling-dependent interaction for the combination of cytosine arabinoside and daunorubicin on HL-60 cells

Haematologica. 1988 Nov-Dec;73(6):466-70.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Drug Administration Schedule
  • Drug Interactions
  • Humans
  • Leukemia / drug therapy*
  • Tumor Cells, Cultured / drug effects

Substances

  • Cytarabine
  • Daunorubicin